Novartis Gets FDA Approval for High Blood Pressure Drug Valturna
Links shared publicly online about this topic
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
novartis.com — “Basel, September 17, 2009 - The US Food and Drug Administration (FDA) has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure[2]. This is the first approval for Valturna, which is indicated for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (AR” View full resource at novartis.com
Most Recently Shared on September 18, 2009 at 7:52 am By:
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren http://twurl.nl/samel4
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
drugs.com — “Valturna (aliskiren and valsartan) is used to treat high blood pressure. Includes Valturna side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 17, 2009 at 11:49 pm By:
FDA Approves Valturna (aliskiren and valsartan) to treat high blood pressure - http://bit.ly/2jfQfe
Valturna approved for treatment of hypertension - MPR
empr.com — “The FDA has approved Valturna (aliskiren and valsartan tablets, from Novartis), a combination agent containing a direct renin inhibitor and an angiotensin receptor blocker, for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (ARB) monotherapy and as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.” View full resource at empr.com
Most Recently Shared on September 18, 2009 at 3:42 pm By:
MPR News: Valturna approved for treatment of hypertension: The FDA has approved Valturna (aliskiren and.. http://bit.ly/QLS85
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Novartis
We provide healthcare solutions that address the evolving needs of patients and societies worldwide.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
